Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03680872 · ClinicalTrials.gov registry record · NA
Restoring Motor and Sensory Hand Function in Tetraplegia Using a Neural Bypass System
A NA study of Spinal Cord Injuries and Spinal Cord Injury Cervical, sponsored by Chad Bouton.
- Recruiting
- Registry status
- NA
- Development phase
- 7
- Enrollment target
- 1
- Study location
NCT03680872: Recruiting NA study of Spinal Cord Injuries and Spinal Cord Injury Cervical, sponsored by Chad Bouton.
NCT03680872 is a NA study of Spinal Cord Injuries and Spinal Cord Injury Cervical that is actively recruiting participants, run by Chad Bouton. The registered enrollment target is 7 participants, below the 62-participant average among 202 other Spinal Cord Injuries trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03680872, a NA study of Spinal Cord Injuries and Spinal Cord Injury Cervical, is actively recruiting participants, sponsored by Chad Bouton.
- RECRUITING
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a single-cohort early feasibility trial to determine whether an investigational device called the Bidirectional Neural Bypass System can lead to the restoration of movement and sensation in the hand and wrist of up to seven individuals with tetraplegia.
Primary Outcome
The primary outcome of restoring movement will be evaluated through Graded Redefined Assessment of Strength, Sensibility \& Prehension. The performance will be graded on a numeric scale from 0-92, where a higher number indicates a better outcome. Participants will complete 10 distinct arm, wrist, and finger movements. The movements will be evaluated on a 5-point scale ranging from no movement to normal movement for a total of 0-50. Participants will be asked to perform a cylindrical grasp, key
Conditions Studied
Interventions
- DEVICE Bidirectional Neural Bypass System
Study Locations (1)
New York
- Northwell Health's The Feinstein Institute for Medical Research - Manhasset
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2019-09-30 |
| Est. Completion | 2028-12 |
| Phase | NA |
What NCT03680872 shows while recruiting
NCT03680872 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 7 participants, a relatively small participant target, below the 62-participant average among 202 other Spinal Cord Injuries trials with a reported enrollment target (89% lower).
The record links to 2 conditions, with Spinal Cord Injuries appearing as the primary indexed condition, and to 1 intervention - of which Bidirectional Neural Bypass System is the first listed.
NCT03680872 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT03680872 about?
NCT03680872 is a clinical study titled "Restoring Motor and Sensory Hand Function in Tetraplegia Using a Neural Bypass System". This is a single-cohort early feasibility trial to determine whether an investigational device called the Bidirectional Neural Bypass System can lead to the restoration of movement and sensation in the hand and wrist of up to seven individuals with tetraplegia.
What is the current status of trial NCT03680872?
This trial is currently recruiting. It is a NA study. The enrollment target is 7 participants. The study started on 2019-09-30. Estimated completion is 2028-12.
What conditions does trial NCT03680872 study?
This clinical trial studies the following conditions: Spinal Cord Injuries, Spinal Cord Injury Cervical.
What interventions are being tested in trial NCT03680872?
The interventions under investigation include: Bidirectional Neural Bypass System (DEVICE).
Who is sponsoring clinical trial NCT03680872?
This trial is sponsored by Chad Bouton, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03680872 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Spinal Cord Injuries
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03680872's enrollment target sits among peer trials
7 182nd of 202 higher than 21 of 202 other Spinal Cord Injuries trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Spinal Cord Injuries trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia (BG-Speech-02)
RECRUITING · NA
-
Closed-loop Spinal Stimulation for Restoration of Upper Extremity Function After Spinal Cord Injury
RECRUITING · NA
-
Neuromodulation to Improve Respiratory Function in Cervical Spinal Cord Injury
RECRUITING · NA
-
Transcutaneous Spinal Stimulation and Exercise for Locomotion
RECRUITING · NA
-
HAPPINESS: cHAnging the Perceived Pain INtEnSity in Populations With Spinal Cord Injury and With Health Disparities: A Feasibility Study
RECRUITING · NA
-
Dosing rTMS for Depression Post-SCI
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy